Başka bir renk deneyin:
Başka bir font büyüklüğü deneyin: 60% 70% 80% 90%


 


SELLING SICKNESS (HASTALIK SATMA, HASTALIK TÜCCARLAR!) KONGRE 2013

 HASTALIK TÜCCARLARI SONUÇ BİLDİRİSİ YAYINLANDI

CALL TO ACTION ON SELLING SICKNESS

 

The Selling Sickness conference of February, 2013 was designed to be part of a global progressive and activist health movement. A CALL TO ACTION statement can help unify professionals, researchers, activists, scholars, caregivers, advocates and all citizens alarmed by disease-mongering.

The statement below was shaped by many contributors and discussed at “Selling Sickness, 2013: People before Profits” in Washington, DC, In February, 2013.

CALL TO ACTION ON SELLING SICKNESS

Washington, DC

We come together as researchers, health care professionals, activists, advocates, patients, caregivers and citizens deeply troubled about the growing corruption of medical science and health care.

We demand an end to industry-promoted disease-mongering that manipulates health concerns and causes harm through practices that medicalise normal life and deceive professionals and the public.

Commercial imperatives are being allowed to corrupt clinical, research and marketing practices which now include hiding data, inflating diagnostic categories, unnecessary screening and treatment, deceptive marketing, faulty and biased research and publishing, inadequate oversight, a neglect of social factors and injustices, and uncritical, unbalanced reporting.

We are alarmed at how undergraduate and post-graduate professional education are based on untrustworthy “science” designed to expand markets rather than impart valid knowledge or improve individual or public health.

Hazardous practices and distorted science harm patients, waste public resources, create illness and health anxiety, hoodwink the public, corrupt knowledge, corrode professionalism, and expose everyone to unnecessary, costly and dangerous tests and treatments.

Recognizing that we all will enact this commitment differently, we pledge our support to a new movement of alliances and actions to ensure that:

   a clear firewall is created between industry/commercial influence, on the one hand, and, on the other, the regulators of drugs and devices as well as the developers and authors of clinical practice guidelines;

   direct-to-consumer advertising of prescription drugs and medical devices is much more tightly regulated or, if possible, is prohibited and effective surveillance programs created;

   drugs, diagnostic tests, and devices are tested, approved, reported and marketed solely with the goal of ensuring patient safety, scientific integrity and individual and public health;

   drugs and devices are tested against appropriate controls, usually the current best treatment, in appropriate populations;

   unsafe or ineffective marketed products are quickly identified, their harms and inadequacies are widely publicized, and they are removed from use;

   all clinical trials are registered and access to all raw clinical trial data is made available for independent analyses at least at the time of approval, but preferably before approval;

   the patent system for medicines is reformed so commercial benefit does not overshadow real clinical benefits for patients;

   patients and health care consumers are fully informed about and involved in individual health decisions, as well as in research priorities, research design, and regulatory policy;

   human subjects participating in clinical trials are adequately protected by ethical review boards that are functioning properly, accurate and complete informed consent, and the provision of full compensation for any harms;

   journalists, whose job it must be to independently vet claims made by third parties, realize the harm that is done when news stories disseminate disease-mongering sales and promotion messages in an unchallenged, unverified manner;

   health care regulations, health professional training, and clinical practice guidelines acknowledge and make allowance for marginalized and vulnerable groups who may be more susceptible to harms and exploitation;

   the usually less profitable non-pharmaceutical treatments and therapies, as well as disease prevention and community-centered interventions, are raised in research and publishing priority to levels comparable to drug and device therapies.

These reforms will substantially improve public health and safety in a complex world of escalating technologies and communications media, and will save money, thereby lessening pressure on individual and public budgets and private health insurance programs.

We believe the urgent threat to human health from disease-mongering requires the united and creative action of citizens and professionals.

We pledge ourselves to act, individually and collectively, to distribute and to implement the measures outlined in this statement and encourage continuing outreach to interested others.

PLEASE SIGN THE STATEMENT TO INDICATE YOUR ENDORSEMENT. 

JOIN OUR GLOBAL MOVEMENT!

 

Latest Signatures


48


Ellen Liversidge


San Diego, Ca


United States


Apr 25, 2013


47


Clark Baker


Los Angeles, Ca


United States


Apr 25, 2013


46


Ignacio Neumann


Hamilton, Ontario


Canada


Apr 25, 2013


45


David Henry


Toronto, Ontario


Canada


Apr 25, 2013


44


Johanna Trimble


Vancouver, Bc


Canada


Apr 25, 2013


43


Gordon Guyatt


Hamilton, Ontario


Canada


Apr 25, 2013


42


Janet Mccabe


Prince Albert, Saskatchewan


Canada


Apr 25, 2013


41


Andreas Vilhelmsson


Malmö, Skåne


Sweden


Apr 25, 2013


40


Thea Cacchioni


Victoria, Bc


Canada


Apr 25, 2013


39


Dan Walter


Deland, Florida


Usa


Apr 25, 2013


38


Toni Bark


Evanston, Illinois


Usa


Apr 25, 2013


37


Tom Lamb


Wilmington, North Carolina


Usa


Apr 25, 2013


36


Joleen Chambers


Dallas, Tx


Usa


Apr 25, 2013


35


Kelly Holloway


Toronto, On


Canada


Apr 25, 2013


34


Jean Rexford


Redding, Ct


Usa


Apr 25, 2013


33


Abby Lippman


Montréal, Québec


 


Apr 25, 2013


32


Peggy Brick


Kennett Square, Pa


Usa


Apr 25, 2013


31


Alexandra Rutherford


Toronto, On


Canada


Apr 25, 2013


30


Judith Levine


Brooklyn, Ny


Us


Apr 25, 2013


29


Edward Opton


 


 


Apr 25, 2013


28


Kathy Day Rn


Bangor, Me


Usa


Apr 25, 2013


27


Marc-Andre Gagnon


Gatineau, Quebec


Canada


Apr 25, 2013


26


Professor Dave Holmes


Ottawa, On


Canada


Apr 25, 2013


25


Marilou Gagnon


Ottawa, Ontario


Canada


Apr 25, 2013


24


Donald Light


Cambridge, Ma


Usa


Apr 25, 2013


23


Kenneth Lin


Washington, Dc


United States


Apr 25, 2013


22


F. Cankat Tulunay


Ankara


Turkey


Apr 25, 2013


21


David Healy


Bangor, Wales


United Kingdom


Apr 25, 2013


20


Janne Leinonen


Helsinki


Finland


Apr 25, 2013


19


Warren Bell


Salmon Arm, Bc


Canada


Apr 25, 2013


18


Alan Cassels


Victoria, Bc


Canada


Apr 25, 2013


17


Dianne Kennedy


Bowral, Nsw


Australia


Apr 25, 2013


16


Amery Schultz


Merritt, Bc


Canada


Apr 25, 2013


15


Karen Langhart


Litchfield Park, Arizona


Usa


Apr 25, 2013


14


Tehseen Noorani


Washington Dc, Dc


Usa


Apr 25, 2013


13


Dee Mangin


Christchurch, Canterbury


New Zealand


Apr 25, 2013


12


Else Marie Schelin


Roskilde


Denmark


Apr 25, 2013


11


Kari Tikkinen


Toronto, Ontario


Canada


Apr 25, 2013


10


Christopher Lane


Chicago, Illinois


Usa


Apr 25, 2013


9


Mary Osborn


Sydney, New South Wales


Australia


Apr 25, 2013


8


Mathy Milling Downing


Laytonsville, Md


Usa


Apr 25, 2013


7


Colleen Fuller


Vancouver, B.C.


Canada


Apr 25, 2013


6


Genevieve Rail


Montreal, Quebec


Canada


Apr 25, 2013


5


Charlene Reilly, Np


Napa, Ca.


United States


Apr 23, 2013


4


Leonore Tiefer


New York, Ny


Usa


Apr 22, 2013


3


Kim Witczak


Minneapolis, Mn


Usa


Apr 18, 2013


2


Elke Hinze


San Clemente, Ca


United States


Apr 04, 2013


1


Susan Rhoades


 


 


Mar 28, 2013